151 results
Page 3 of 8
8-K
EX-10.1
yusb3n
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
1u2j 53nix7yz0y
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.2
wfuxbz3lu
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.3
pf41v45i2 6qveh
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K/A
EX-99.2
28u3j zgg0x1gdo
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K/A
EX-99.1
ryt3w5tasdm70
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K
EX-10.1
bqwi ov9zf
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
DEFM14C
cxvly2iv5 u9
31 Aug 20
Information related to merger
7:00am
8-K/A
EX-99.1
kht0g0n7eavsrrpmyc95
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
8-K/A
EX-99.3
angg4a hw
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
PREM14C
f3mgshs
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
EX-3.2
bt92iko48
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-4.1
zjvflqbcwsp1x
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.3
7qytfrrh3 b0
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.4
bcg25xa
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.1
lb7o3b4
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.1
bi1ewwxg
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
plu1pjtg wh
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
SC 14F1
ivxewrd8aph7zdb3u4gc
8 Jun 20
Statement regarding change in majority of directors
11:05am
8-K
EX-2.1
fe2jmmpkt2 5xnro
13 May 20
Entry into a Material Definitive Agreement
5:10pm